Alternatively, noninvasive markers are promising for predicting EGFR mutation.16, 17 Cancers with different genotypes drive specific biological processes involved in the development and progression of tumors, thus ultimately leading to different phenotypes. The gene discussed is EGFR; the disease is cancer.